Exelixis Announces U.S. FDA Approval of Cabometyx (cabozantinib) Tablets for Previously Treated Hepatocellular Carcinoma

Print this page ALAMEDA, Calif.–(BUSINESS WIRE)–Jan. 14, 2019– Exelixis, Inc. (NASDAQ:EXEL) today announced that the U.S. Food and Drug Administration (FDA) approved Cabometyx (cabozantinib) tablets for patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib. HCC is the most common form of liver cancer and the fastest-rising cause of cancer-related death in… Read More »

Virtual video visits may improve patient convenience without sacrificing quality of care

A team of researchers at Harvard-affiliated Massachusetts General Hospital (MGH) reports in the American Journal of Managed Care that virtual video visits, one form of telehealth visit used at the hospital, can successfully replace office visits for many patients without compromising the quality of care and communication. Virtual video visits are personal video chats between a health… Read More »

Arkansas Medicaid rolls fall by 18,000 after 7 months of work requirements

An additional 1,232 people failed to meet Arkansas’ Medicaid work requirement in December, for a total of 18,000 people dropped from government-funded coverage since the rules kicked in seven months ago. The latest tally will continue to offer fodder to critics who say the state’s requirements are ineffective at their goal of moving people from… Read More »

  1. Pages:
  3. 1
  5. 868
  6. 869
  7. 870
  8. 871
  9. 872
  10. 873
  11. 874
  13. 1209